Neogenomics Inc (NASDAQ:NEO)

11.17
Delayed Data
As of Dec 01
 -0.04 / -0.36%
Today’s Change
6.00
Today|||52-Week Range
35.70
-67.28%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 16.00, with a high estimate of 26.00 and a low estimate of 7.10. The median estimate represents a +43.30% increase from the last price of 11.17.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$130.0M
Reporting Date
Feb 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -17.58%
 
 
 
 
 
 
Growthannually -153.28%
 
 
 
 
 
 

Sales

Growthquarterly 0.92%
 
 
 
 
 
 
Growthannually 3.46%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.